To determine whether disruption of the hepatic sinusoidal endothelium will facilitate engraftment of transplanted cells, we treated Fischer 344 (F344) rats lacking dipeptidyl peptidase IV (DPPIV) activity with cyclophosphamide (CP). Electron microscopy showed endothelial injury within 6 hours following CP, and, after 24 and 48 hours, the endothelium was disrupted in most hepatic sinusoids. CP did not affect Kupffer cell function. Similarly, CP had no obvious effects on hepatocytes. Intrasplenic transplantation of F344 rat hepatocytes followed by their localization with DPPIV histochemistry showed 3-to 5-fold increases in the number of transplanted cells in CP-treated animals. Transplanted cells integrated in the liver parenchyma more rapidly in CPtreated animals, and hybrid bile canaliculi developed even 1 day after cell transplantation, which was not observed in control animals. To demonstrate whether improved cell engraftment translated into superior liver repopulation, recipient animals were conditioned with retrorsine and two-thirds partial hepatectomy (PH), which induces transplanted cell proliferation. CP treatment of these animals before cell transplantation significantly increased the number and size of transplanted cell foci. In conclusion, disruption of the hepatic sinusoidal endothelium was associated with accelerated entry and integration of transplanted cells in the liver parenchyma. These results provide insights into hepatocyte engraftment in the liver and will help in optimizing liver-directed cell therapy. ( T ransplanted hepatocytes integrate in the liver, survive throughout the life of animals, and express genes normally. 1-3 However, several days are required for transplanted cells to integrate in the liver parenchyma. 4 Moreover, transplanted cells do not proliferate significantly in the normal adult liver, 3 although, when proliferation and/or survival of native and transplanted cells are dissociated, transplanted hepatocytes can repopulate the liver extensively. [5][6][7][8][9][10] The possibility of therapeutic liver repopulation has been tested in several animal models with liver failure, genetic diseases, and metabolic deficiency states. [11][12][13][14] The swiftness with which transplanted cells engraft could be critical for liver repopulation. After injection into the portal system, transplanted cells lodge in hepatic sinusoids because of differences in the dimensions of these cells and sinusoids. 15 This is associated with changes in native hepatocytes, such as gamma-glutamyl transpeptidase activation and disruption of gap junctions. 16 The sinusoidal endothelium is disrupted 16 to 20 hours after transplantation, which provides transplanted cells access to the space of Disse. 4 Transplanted cells then translocate into the liver plate, with reconstitution of gap junctions and bile canaliculi over 3 to 7 days. However, delays in cell engraftment affect transplanted cell proliferation. In rats subjected to two-thirds partial hepatectomy (PH), which induces hepatic DNA synthesis within ...